Cargando…
lncRNAs PVT1 and HAR1A are prognosis biomarkers and indicate therapy outcome for diffuse glioma patients
Diffuse gliomas are well known malignant brain tumors. Long non-coding RNAs (lncRNAs), a type of RNA transcript with more than 200 nucleotides, involve in tumorigenesis and development of various cancers. This study focused on identifying differentially expressed lncRNAs in gliomas based on gene exp...
Autores principales: | Zou, Hecun, Wu, Lan-Xiang, Yang, Yonglong, Li, Shuang, Mei, Ying, Liu, Yong-Bin, Zhang, Lihua, Cheng, Yu, Zhou, Hong-Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667997/ https://www.ncbi.nlm.nih.gov/pubmed/29108264 http://dx.doi.org/10.18632/oncotarget.20226 |
Ejemplares similares
-
Identification of cuproptosis‐related lncRNAs for prognosis and immunotherapy in glioma
por: Wang, Lin, et al.
Publicado: (2022) -
Identification of Novel tRNA-Leu-CAA-Derived tsRNAs for the Diagnosis and Prognosis of Diffuse Gliomas
por: Xu, Bing, et al.
Publicado: (2022) -
Regulation of temozolomide resistance via lncRNAs: Clinical and biological properties of lncRNAs in gliomas (Review)
por: Li, Sui, et al.
Publicado: (2022) -
Risk assessment model constructed by differentially expressed lncRNAs for the prognosis of glioma
por: Hu, Chenggong, et al.
Publicado: (2018) -
Identification of Prognostic LncRNAs Subtypes Predicts Prognosis and Immune Microenvironment for Glioma
por: Chen, Fei, et al.
Publicado: (2022)